Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-250,310
Closed -$16.8M 472
2025
Q3
$16.8M Buy
250,310
+56,062
+29% +$4.44M 0.15% 109
2025
Q2
$17M Sell
194,248
-2,060
-1% -$161K 0.16% 102
2025
Q1
$13.4M Buy
196,308
+4,349
+2% +$355K 0.15% 105
2024
Q4
$14.9M Buy
191,959
+182,059
+1,839% +$13.5M 0.18% 90
2024
Q3
$664K Sell
9,900
-90
-0.9% -$7.39K 0.01% 324
2024
Q2
$1.13M Sell
9,990
-130
-1% -$16.4K 0.01% 261
2024
Q1
$1.4M Sell
10,120
-110
-1% -$13.8K 0.02% 254
2023
Q4
$1.27M Sell
10,230
-55,819
-85% -$5.7M 0.02% 273
2023
Q3
$6.16M Buy
66,049
+7,036
+12% +$793K 0.09% 144
2023
Q2
$7.58M Buy
59,013
+53,703
+1,011% +$6.5M 0.1% 127
2023
Q1
$617K Buy
5,310
+2,221
+72% +$249K 0.01% 270
2022
Q4
$350K Buy
+3,089
New +$339K 0.01% 325
2022
Q1
Sell
-27,052
Closed -$3.63M 422
2021
Q4
$3.63M Buy
+27,052
New +$3.89M 0.02% 193
2021
Q1
Sell
-36,184
Closed -$3.34M 396
2020
Q4
$3.34M Buy
36,184
+19,816
+121% +$1.77M 0.02% 166
2020
Q3
$1.69M Buy
16,368
+4,804
+42% +$502K 0.02% 199
2020
Q2
$1.17M Buy
+11,564
New +$1.03M 0.02% 199

Other funds holding DXCM

Banco Santander's DXCM Position: Q4 2025 in Review

Banco Santander sold out of DexCom (DXCM) in Q4 2025, closing a stake of 250,310 shares — an estimated $16.8M sold.

Banco Santander first reported a position in DXCM in Q2 2020 and held it in 16 quarters. The position peaked at $17M in Q2 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Banco Santander reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Banco Santander sold 250,310 DexCom shares in Q4 2025, an estimated $16.8M.
  • Banco Santander first reported a position in DexCom in Q2 2020 and held it in 16 quarters.
  • Banco Santander's DexCom position peaked at $17M in Q2 2025.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Banco Santander's 13F filing for Q4 2025, filed 13 Feb 2026.